Shares of Vitamin Shoppe, Inc (NYSE:VSI) shot up 9.1% during mid-day trading on Monday . The company traded as high as $4.20 and last traded at $4.20. 584,000 shares changed hands during trading, an increase of 13% from the average session volume of 514,690 shares. The stock had previously closed at $3.85.
A number of brokerages have issued reports on VSI. Morgan Stanley set a $8.00 price target on shares of Vitamin Shoppe and gave the stock a “hold” rating in a research note on Thursday, August 10th. Goldman Sachs Group, Inc. (The) reiterated a “sell” rating and set a $6.00 price target (down from $13.00) on shares of Vitamin Shoppe in a research note on Thursday, August 10th. Barclays PLC cut their price target on shares of Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 9th. TheStreet lowered shares of Vitamin Shoppe from a “c-” rating to a “d” rating in a research note on Wednesday, August 9th. Finally, BidaskClub lowered shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Four analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $5.00.
The company has a quick ratio of 0.32, a current ratio of 2.07 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $98.31, a P/E ratio of 4.41 and a beta of 0.74.
Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. The firm had revenue of $288.20 million for the quarter, compared to analysts’ expectations of $297.61 million. During the same quarter in the previous year, the company posted $0.50 earnings per share. The firm’s quarterly revenue was down 8.5% on a year-over-year basis. equities analysts forecast that Vitamin Shoppe, Inc will post 0.44 earnings per share for the current fiscal year.
In related news, Director John D. Bowlin purchased 40,000 shares of the company’s stock in a transaction on Friday, August 25th. The shares were bought at an average cost of $5.50 per share, for a total transaction of $220,000.00. Following the completion of the purchase, the director now directly owns 56,028 shares of the company’s stock, valued at approximately $308,154. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.07% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently made changes to their positions in VSI. GMT Capital Corp purchased a new position in Vitamin Shoppe in the third quarter valued at approximately $3,423,000. Canada Pension Plan Investment Board increased its stake in Vitamin Shoppe by 175.5% in the third quarter. Canada Pension Plan Investment Board now owns 652,600 shares of the specialty retailer’s stock valued at $3,491,000 after purchasing an additional 415,700 shares during the last quarter. FMR LLC increased its stake in Vitamin Shoppe by 32.4% in the second quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock valued at $14,617,000 after purchasing an additional 307,050 shares during the last quarter. Vanguard Group Inc. increased its stake in Vitamin Shoppe by 14.8% in the first quarter. Vanguard Group Inc. now owns 2,186,549 shares of the specialty retailer’s stock valued at $44,059,000 after purchasing an additional 282,598 shares during the last quarter. Finally, Systematic Financial Management LP increased its stake in Vitamin Shoppe by 94.9% in the third quarter. Systematic Financial Management LP now owns 217,345 shares of the specialty retailer’s stock valued at $1,163,000 after purchasing an additional 105,855 shares during the last quarter. Institutional investors own 85.35% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Vitamin Shoppe, Inc (VSI) Shares Up 9.1%” was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://sportsperspectives.com/2017/11/22/vitamin-shoppe-inc-vsi-shares-up-9-1.html.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.